Clinical Trial Update: Dynamic Contrast Enhanced Magnetic Resonance Perfusion Imaging in Congenital Heart Disease and Lung Disease [Phase 3]

View source ↗

Summary

Phase 3 trial update on dynamic contrast enhanced MRI perfusion imaging in congenital heart disease and lung disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Cystic Fibrosis
• Heart Disease

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Heart Disease, Cystic Fibrosis | Phase 3 | Status: COMPLETED